An Ultrasensitive Method for Detection of Cell-Free RNA

Histology - Cancer histology at sample collection date. (phv00568775.v1.p1)
IS_TUMOR - Sample tumor status (yes/no) (phv00568785.v1.p1)
Stage - Cancer stage at sample collection date. Stage was determined using American Joint Committee on Cancer (AJCC) 8th edition. (phv00568776.v1.p1)

ANALYTE_TYPE - Sample analyte type (RNA/DNA) (phv00568784.v1.p1)
BCT - Tube type used for sample collection. (phv00568778.v1.p1)
BODY_SITE - Sample collection site (phv00568783.v1.p1)
ColID - De-identified label indicating the blood collection ("C") date or timepoint ("TP") for each unique sample for each subject or patient (phv00568773.v1.p1)
CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00568763.v1.p1)
DAYS_FROM_DIAGNOSIS - Time (days) from cancer diagnosis for subjects used in longitudinal EGFR TKI analysis. (phv00568786.v1.p1)
group - Subject groups used in this study. (phv00568768.v1.p1)
pg_input - Plasma RNA input (pg) (phv00568782.v1.p1)
plasma_conc_ng_mL - Plasma cfRNA concentration (ng/mL) (phv00568781.v1.p1)
SAMPLE_ID - Sample ID (phv00568772.v1.p1)
SAMPLE_ID - Sample ID (phv00568766.v1.p1)
Selector - Rare Abundance Gene (RAG) panel used for hybrid capture. Two versions of the panel were used in our study: Version 1 (V1) and Version 2 (V2) (phv00568780.v1.p1)
Source - Institution where sample collected. (phv00568777.v1.p1)
Spin - Centrifugation speed used to isolate plasma. Sequential centrifugation steps are denoted with "+". (phv00568779.v1.p1)
SUBJECT_ID - Subject ID (phv00568767.v1.p1)
SUBJECT_ID - Subject ID (phv00568762.v1.p1)
SUBJECT_ID - Subject ID (phv00568765.v1.p1)